149 related articles for article (PubMed ID: 8285642)
1. Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin.
McWhinney PH; Patel S; Whiley RA; Hardie JM; Gillespie SH; Kibbler CC
Antimicrob Agents Chemother; 1993 Nov; 37(11):2493-5. PubMed ID: 8285642
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients.
Alcaide F; Carratala J; Liñares J; Gudiol F; Martin R
Antimicrob Agents Chemother; 1996 Sep; 40(9):2117-20. PubMed ID: 8878591
[TBL] [Abstract][Full Text] [Related]
3. Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients.
Wisplinghoff H; Reinert RR; Cornely O; Seifert H
J Clin Microbiol; 1999 Jun; 37(6):1876-80. PubMed ID: 10325340
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients.
Venditti M; Baiocchi P; Santini C; Brandimarte C; Serra P; Gentile G; Girmenia C; Martino P
Antimicrob Agents Chemother; 1989 Apr; 33(4):580-2. PubMed ID: 2729950
[TBL] [Abstract][Full Text] [Related]
5. Surveillance of antibiotic resistance in clinical isolates of Streptococcus pneumoniae collected in Belgium during winter 2000-2001.
Vanhoof R; Carpentier M; Cartuyvels R; Damée S; Fagnart O; Garrino MG; Glupczynski Y; Gordts B; Govaerts D; Magerman K; Mans I; Surmont I; Van Bossuyt E; Van De Vyvere M; Van Landuyt H; Van Nimmen L; Van Noyen R
Acta Clin Belg; 2003; 58(2):111-9. PubMed ID: 12836494
[TBL] [Abstract][Full Text] [Related]
6. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs.
Traub WH; Leonhard B
Chemotherapy; 1997; 43(1):10-20. PubMed ID: 8996736
[TBL] [Abstract][Full Text] [Related]
7. Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group.
Pfaller MA; Jones RN; Marshall SA; Edmond MB; Wenzel RP
Diagn Microbiol Infect Dis; 1997 Dec; 29(4):259-63. PubMed ID: 9458983
[TBL] [Abstract][Full Text] [Related]
8. Susceptibilities of streptococcal strains associated with infective endocarditis to nine antibiotics.
Etienne J; Coulet M; Brun Y; Blanchon JF; Demoux F; Fleurette J
Chemotherapy; 1988; 34(2):113-6. PubMed ID: 3391051
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility of viridans group streptococci.
Tuohy M; Washington JA
Diagn Microbiol Infect Dis; 1997 Dec; 29(4):277-80. PubMed ID: 9458986
[TBL] [Abstract][Full Text] [Related]
10. Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin.
King A; Bathgate T; Phillips I
Clin Microbiol Infect; 2002 Feb; 8(2):85-92. PubMed ID: 11952721
[TBL] [Abstract][Full Text] [Related]
11. Activities of new fluoroquinolones, ketolides, and other antimicrobials against blood culture isolates of viridans group streptococci from across Canada, 2000.
Gershon AS; de Azavedo JC; McGeer A; Ostrowska KI; Church D; Hoban DJ; Harding GK; Weiss K; Abbott L; Smaill F; Gourdeau M; Murray G; Low DE;
Antimicrob Agents Chemother; 2002 May; 46(5):1553-6. PubMed ID: 11959597
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of dalbavancin against multidrug-resistant Staphylococcus aureus and streptococci from patients with documented infections in Europe and surrounding regions (2011-2013).
Huband MD; Castanheira M; Farrell DJ; Flamm RK; Jones RN; Sader HS; Mendes RE
Int J Antimicrob Agents; 2016 Jun; 47(6):495-9. PubMed ID: 27211209
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of cefepime and ceftazidime against 197 nosocomial blood stream isolates of streptococci: a multicenter sample.
Pfaller MA; Marshall SA; Jones RN
Diagn Microbiol Infect Dis; 1997 Dec; 29(4):273-6. PubMed ID: 9458985
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
Visalli MA; Jacobs MR; Appelbaum PC
Diagn Microbiol Infect Dis; 1997 Jul; 28(3):131-7. PubMed ID: 9294703
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site model.
Peterson LR; Moody JA; Fasching CE; Gerding DN
Diagn Microbiol Infect Dis; 1987 Jun; 7(2):127-36. PubMed ID: 3115671
[TBL] [Abstract][Full Text] [Related]
16. Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacin.
Pfaller MA; Jones RN
Diagn Microbiol Infect Dis; 1997 Nov; 29(3):199-201. PubMed ID: 9401813
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study Group.
Ballow CH; Jones RN; Johnson DM; Deinhart JA; Schentag JJ
Diagn Microbiol Infect Dis; 1997 Nov; 29(3):173-86. PubMed ID: 9401810
[TBL] [Abstract][Full Text] [Related]
18. A randomized prospective study of ceftazidime and ciprofloxacin with or without teicoplanin as an empiric antibiotic regimen for febrile neutropenic patients.
Lim SH; Smith MP; Goldstone AH; Machin SJ
Br J Haematol; 1990 Dec; 76 Suppl 2():41-4. PubMed ID: 2149051
[TBL] [Abstract][Full Text] [Related]
19. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.
Presterl E; Grisold AJ; Reichmann S; Hirschl AM; Georgopoulos A; Graninger W
J Antimicrob Chemother; 2005 Jan; 55(1):45-50. PubMed ID: 15563519
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America.
Diekema DJ; Beach ML; Pfaller MA; Jones RN;
Clin Microbiol Infect; 2001 Mar; 7(3):152-7. PubMed ID: 11318814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
